Rnhale
RNhale GmbH is a spin-off originating from the Ludwig-Maximilians-University Munich, aiming to revolutionize the pharmaceutical landscape by developing a unique platform technology for formulating RNA-loaded lipid nanoparticles (LNPs) as an inhalable dry powder. This disruptive approach synergizes technological and pharmaceutical strategies to create a novel therapeutic formulation with significant advantages over common LNP-RNA delivery methods. The target is pulmonary diseases with vast addressable markets and undeniable medical needs.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Rnhale
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
Showing 1 of 4 verified contacts
Top roles at Rnhale
4 distinct titles indexed · top 4 shown.
- 1business and growth strategist
- 1co-founder & chief scientific officer (cso)
- 1co-founder, cto
- 1junior scientist
Sign up to unlock all 4 contacts at Rnhale
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Rnhale
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.